tiprankstipranks
Advertisement
Advertisement
Vivos Therapeutics signs 12-part media series with New to the Street
PremiumThe FlyVivos Therapeutics signs 12-part media series with New to the Street
2M ago
Vivos Therapeutics Completes Warrant Inducement Financing Transaction
Premium
Company Announcements
Vivos Therapeutics Completes Warrant Inducement Financing Transaction
2M ago
Vivos Therapeutics Secures Convertible Bridge Financing Facility
Premium
Company Announcements
Vivos Therapeutics Secures Convertible Bridge Financing Facility
2M ago
Vivos Therapeutics Reports Revenue Growth Amid Strategic Shift
PremiumCompany AnnouncementsVivos Therapeutics Reports Revenue Growth Amid Strategic Shift
4M ago
Vivos Therapeutics reports Q3 EPS (49c), consensus (51c)
Premium
The Fly
Vivos Therapeutics reports Q3 EPS (49c), consensus (51c)
4M ago
Vivos Therapeutics initiated with a Buy at H.C. Wainwright
Premium
The Fly
Vivos Therapeutics initiated with a Buy at H.C. Wainwright
4M ago
Vivos Therapeutics announces trial results in pediatric OSA treatment
PremiumThe FlyVivos Therapeutics announces trial results in pediatric OSA treatment
6M ago
Strategic Growth and Market Expansion: Vivos Therapeutics’ Buy Rating and Raised Price Target
Premium
Ratings
Strategic Growth and Market Expansion: Vivos Therapeutics’ Buy Rating and Raised Price Target
7M ago
Vivos Therapeutics’ Earnings Call: Strategic Transition and Growth
Premium
Company Announcements
Vivos Therapeutics’ Earnings Call: Strategic Transition and Growth
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100